Cortechs.ai plans to collaborate with the Alzheimer's Network for Treatment and Diagnostics (ALZ-NET) to improve Alzheimer's disease care.
The partnership will combine Cortechs.ai's NeuroQuant brain MRI software for amyloid-related imaging abnormalities with ALZ-NET's data network.
NeuroQuant for amyloid-related imaging abnormalities offers segmentation, quantification, and longitudinal tracking of lesions on both 2D and 3D FLAIR and T2*-weighted gradient-recalled echo and susceptibility-weighted imaging MRI sequences, Cortechs.ai said.
.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=100&q=70&w=100)
.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=167&q=70&w=250)
